Market Access A year of major M&A ahead? The previous few years have seen a slowdown in M&A across the industry, as companies take a cautious approach to expansion.
News Chiesi expands rare disease portfolio with Amryt Pharma acqu... Biopharma and healthcare group Chiesi Farmaceutici S.p.A.
News Boost for mRNA as Moderna to acquire OriCiro for $85 million Biotech Moderna, Inc. and OriCiro Genomics K.K.